ArticleBMC cancer2024

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

Maximilian Mastall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.